跳至主要内容
临床试验/KCT0008028
KCT0008028招募中未知

Observational study of herbal medicine treatment for osteoporosis and osteopenia patients

Daejeon Korean Medicine Hospital of Daejeon University0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
40(Year) 至 80(Year)(—)
性别
All

入选标准

  • 1. Adults between 40 and 80 year old
  • 2. Those diagnosed with osteopenia or osteoporosis with a T-score of less than -1 on the bone density test using DXA
  • 3. Person who voluntarily signed the consent form after being fully explained about this human application test

排除标准

  • 1. If you are taking standard treatment for osteoporosis (Osteoporosis treatment such as bisphosphonate, parathyroid hormone, RANKL inhibitor)
  • 2. A person suffering from the following diseases that can affect bone metabolism
  • - Endocrine and metabolic diseases (thyroid, hyperparathyroidism, uncontrolled diabetes, Cushing's syndrome, hyperprolactinemia, hypogonadism, hypopituitarism, etc.)
  • - Respiratory diseases (chronic obstructive pulmonary disease, asthma)
  • - Chronic renal failure
  • - rheumatic disease
  • - Digestive diseases (absorption disorders, gastrectomy, inflammatory bowel disease, chronic liver disease)
  • - Bone marrow disease (multiple myeloma, lymphoma, leukemia, hemolytic anemia)
  • - Malignant tumors (blood cancer, breast cancer, digestive system cancer)
  • - Taking immunosuppressive drugs after organ transplant
  • 3. A person whose hypertension and hyperglycemia are not controlled despite taking treatment
  • 4. Those who are taking glucocorticoid drugs that cause secondary osteoporosis or other drugs that can affect bone metabolism (PPI, SSRI, TZD, other types of anticonvulsants, etc.)
  • 5. Those who have difficulty in visiting the hospital for research due to problems with walking and movement due to other musculoskeletal disorders
  • 6. Those who have a disease that can affect drug absorption or have digestive problems after surgery related to it
  • 7. Severe liver or kidney disease (at the time of screening, AST, ALT, ?-GTP, and serum creatinine are more than twice the upper limit of normal)
  • 8. Pregnant, lactating or planning to become pregnant
  • 9. Patients who participated in other clinical trials within 3 months
  • 10. If the researcher determines that participation in a clinical study is inappropriate due to other reasons (hypercalcemia of 10.5 mg/dl or more, patients with underlying diseases accompanied by abnormal lipid metabolism, patients with serious underlying diseases, etc.)

研究者

发起方
Daejeon Korean Medicine Hospital of Daejeon University

相似试验